Data / Drug companies / Testosterone cypionate
Testosterone cypionate: 24 companies and 61 products in the FDA NDC directory
Testosterone cypionate is listed in the FDA National Drug Code Directory by 24 companies, with 61 products in commercial distribution. 59 of the products (96.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, and the newest product started marketing on September 14, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 24
- Products
- 61
- Generic (ANDA) products
- 59 (96.7%)
- Application numbers
- 11
- Controlled substance schedule
- Schedule III
- Routes
- Intramuscular
- Brand names
- Depo-Testosterone, Azmiro
- openFDA record search
- api.fda.gov
Companies that list testosterone cypionate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Asclemed USA, Inc. | 7 | injection, solution; injection | Generic drugs (ANDA) | November 2, 2022 |
| A-S Medication Solutions | 6 | injection, solution; injection | Generic drugs (ANDA) | November 1, 2024 |
| Pharmacia & Upjohn Company LLC | 4 | injection, solution | Generic drugs (ANDA) | July 1, 2014 |
| Bryant Ranch Prepack | 3 | injection, solution | Generic drugs (ANDA) | May 1, 2014 |
| Bryant Ranch Prepack | 3 | injection, solution; injection | Generic drugs (ANDA) | May 31, 2019 |
| Cipla USA Inc. | 3 | injection; injection, solution | Generic drugs (ANDA) | September 15, 2023 |
| Eugia US LLC | 3 | injection, solution | Generic drugs (ANDA) | October 20, 2023 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection | Generic drugs (ANDA) | November 22, 2021 |
| NuCare Pharmaceuticals,Inc. | 3 | injection, solution; injection | Generic drugs (ANDA) | November 2, 2022 |
| Sun Pharmaceutical Industries, Inc. | 3 | injection, solution | Generic drugs (ANDA) | June 17, 2013 |
| Xiromed, LLC | 3 | injection, solution | Generic drugs (ANDA) | April 28, 2023 |
| Ajenat Pharmaceuticals LLC | 2 | injection, solution | Generic drugs (ANDA) | September 14, 2026 |
| Alvogen Inc. | 2 | injection, solution | Generic drugs (ANDA) | November 2, 2022 |
| Azurity Pharmaceuticals, Inc. | 2 | injection, solution | New drug applications (NDA) | October 4, 2024 |
| Bpi Labs LLC | 2 | injection, solution | Generic drugs (ANDA) | September 14, 2026 |
| Bryant Ranch Prepack | 2 | injection, solution | Generic drugs (ANDA) | May 1, 2014 |
| Hospira, Inc. | 2 | injection, solution | Generic drugs (ANDA) | August 1, 2016 |
| Padagis US LLC | 2 | injection, solution | Generic drugs (ANDA) | May 1, 2014 |
| Asclemed USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 1, 2014 |
| NorthStar RxLLC | 1 | injection, solution | Generic drugs (ANDA) | November 1, 2024 |
| Proficient Rx LP | 1 | injection | Generic drugs (ANDA) | May 1, 2012 |
| Proficient Rx LP | 1 | injection | Generic drugs (ANDA) | May 1, 2012 |
| Remedyrepack Inc. | 1 | injection | Generic drugs (ANDA) | December 17, 2025 |
| Wilshire Pharmaceuticals, Inc. | 1 | injection | Generic drugs (ANDA) | May 31, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 48 | 78.7% |
| Injection | 13 | 21.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 59 | 96.7% |
| New drug applications (NDA) | 2 | 3.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Androgen | 61 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.